Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$864K Sell
35,867
-2,444
-6% -$63.9K 0.06% 341
2026
Q1
$1.08M Buy
38,311
+1,447
+4% +$38.5K 0.08% 264
2025
Q4
$918K Sell
36,864
-3,133
-8% -$79K 0.07% 300
2025
Q3
$1.02M Buy
39,997
+1,881
+5% +$46.4K 0.08% 279
2025
Q2
$923K Sell
38,116
-16,191
-30% -$378K 0.08% 294
2025
Q1
$1.38M Buy
54,307
+54,253
+100,469% +$1.42M 0.12% 191
2024
Q4
$1.44K Sell
54
-61,780
-100% -$1.68M 0.13% 173
2024
Q3
$1.79M Buy
61,834
+407
+0.7% +$11.9K 0.15% 138
2024
Q2
$1.72M Buy
61,427
+578
+0.9% +$15.9K 0.16% 131
2024
Q1
$1.69M Sell
60,849
-1,630
-3% -$45.2K 0.16% 130
2023
Q4
$1.8M Sell
62,479
-8,716
-12% -$263K 0.18% 116
2023
Q3
$2.36M Buy
+71,195
New +$2.52M 0.26% 84

Other funds holding PFE

NBC Securities's PFE Position: Q2 2026 in Review

NBC Securities reduced its Pfizer (PFE) stake by 6.4% in Q2 2026, selling an estimated $63.9K and leaving 35,867 shares worth $864K. The position accounts for 0.06% of the portfolio, ranked #341.

NBC Securities first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.36M in Q3 2023. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • NBC Securities held 35,867 shares of Pfizer worth $864K as of Q2 2026.
  • NBC Securities sold 2,444 Pfizer shares in Q2 2026, an estimated $63.9K.
  • Pfizer made up 0.06% of NBC Securities's portfolio in Q2 2026, its #341 holding.
  • NBC Securities first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Pfizer position peaked at $2.36M in Q3 2023.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.